Sign In
test

Sven H. Borho

Orbimed Advisors Llc

Assets Managed
$5.045B
Holdings
110
Last Quarter
2026 - Q1
Filed Date
19d ago
Growth Rate
2.98%(2Q avg: 9.06%)
Sustained Growth
3 quarters

Portfolio positions

This chart displays the top 10 holdings in Orbimed Advisors Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 110 positions.

Assets under management

The assets under management (AUM) of Orbimed Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 5.045B in assets, with a quarterly growth rate of 2.98% and a 2-quarter average growth rate of 9.06%. The portfolio is managed by Sven H. Borho, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
EWTX
Edgewise Therapeutics Inc
Recent Activity
9.69%
$488.832M
15.518M shares@ $31.5 avg price
ELVN
Enliven Therapeutics Inc
Recent Activity
6.19%
$312.014M
7.96M shares@ $39.21 avg price
MDXH
Mdxhealth
Recent Activity
New Position
5.67%
$285.904M↑ Call
124.306M shares@ $2.3 avg price
LLY
Eli Lilly & Co
Recent Activity
Decreased -21.38%
4.32%
$217.802M
236,800 shares@ $919.77 avg price
RCEL
Avita Medical Inc
Recent Activity
New Position
3.91%
$196.958M
82.011M shares@ $2.41 avg price
SVA
Sinovac Biotech Ltd
Recent Activity
3.66%
$184.466M
2.719M shares@ $67.86 avg price
BSX
Boston Scientific Corp
Recent Activity
Decreased -1.53%
2.97%
$149.477M
2.382M shares@ $62.75 avg price
SION
Sionna Therapeutics Inc
Recent Activity
Decreased -0.86%
2.81%
$141.546M
3.531M shares@ $40.09 avg price
AZNCF
Astrazeneca Plc
Recent Activity
New Position
2.62%
$132.177M
670,200 shares@ $197.22 avg price
MYGN
Myriad Genetics Inc
Recent Activity
New Position
2.44%
$122.875M
125M shares@ $0.99 avg price

1-10 of 110